Newbury Pharmaceuticals AB Logo

Newbury Pharmaceuticals AB

NEWBRY | ST

Overview

Corporate Details

ISIN(s):
SE0015244884
LEI:
549300F7XHU3I8CWL373
Country:
Sweden
Address:
Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company founded in 2020. It focuses on building and marketing a portfolio of proprietary and licensed specialty prescription drugs and branded products. The company operates primarily in the Scandinavian market, positioning itself as a local alternative to multinational corporations. Its product pipeline is concentrated on providing treatment solutions within key therapeutic areas, including oncology, rare diseases, and neurology.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Newbury Pharmaceuticals AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2018-10-05 13:14
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
English 10.7 KB
2017-06-29 13:30
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
English 11.1 KB

Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-29 Johan Strömqvist Other Sell 13,564 40,692.00 SEK
2025-04-29 Johan Strömqvist Other Sell 10,400 30,888.00 SEK
2025-04-29 Johan Strömqvist Other Buy 10,200 30,804.00 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,570.50 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,200.00 SEK
2025-04-29 Johan Strömqvist Other Sell 2,436 7,332.36 SEK
2025-04-29 Johan Strömqvist Other Sell 100 305.00 SEK
2024-08-03 Andreas Hedskog Other Buy 200,000 178,000.00 SEK
2024-08-03 Andreas Hedskog Other Other 200,000 N/A
2024-01-22 Alsakali Equity AB Other Buy 4,000 18,920.00 SEK

Peer Companies

Company Country Ticker View
Bulgaria PHRM
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands PHARM
Pharmocann Global Ltd. Logo
Develops, cultivates, and distributes pharmaceutical-grade medical cannabis products like oils/tablets.
Israel PMCN-M
Photocure ASA Logo
Develops photodynamic tech that makes bladder cancer cells glow for improved detection.
Norway PHO
Pierrel Logo
Global pharma firm making dental anesthetics & offering contract manufacturing services.
Italy PRL
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland CRM
RaQualia Pharma Inc. Logo Japan 4579
Recordati Industria Chimica e Farmaceutica Logo
Develops, manufactures, and sells drugs for common and rare diseases and APIs globally.
Italy REC